Reproducibility Study of Overactive Bladder Symptom Score [OABSS]

Astellas Pharma Inc50 enrolled

Overview

The purpose of this study is to evaluate its reproducibility of overactive bladder symptom score (OABSS) and to evaluate its correlation to other measures of OAB symptoms.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Overactive Bladder

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Symptoms OAB for 3 months or longer * At least 1 urgency episode in last 3 days * Symptoms of OAB as verified by 3-day micturition diary prior to Visit 1, defined by: * Number of micturition per day ≥8 * Number of urgency episodes in 3 days ≥1 Exclusion Criteria: * Significant stress incontinence or mixed stress/urge incontinence * Subjects with indwelling catheters or practicing intermittent self-catheterization * Symptomatic urinary tract infection, chronic inflammation * Diabetic neuropathy * Drug or non-drug treatment for OAB was started, quitted or changed in 4 weeks * Participation in any clinical trial in 30 days

Locations (3)

Unnamed facility

Bandung, Indonesia

Unnamed facility

Jakarta, Indonesia

Unnamed facility

Surabaya, Indonesia

Outcomes

Primary Outcomes

OABSS

Time frame: Weeks 0 and 2

Secondary Outcomes

International Prostate Symptom Score (IPSS)

Time frame: Weeks 0 and 2

Quality of Life (QOL) score

Time frame: Weeks 0 and 2

Patient Perception of Bladder Condition (PPBC)

Time frame: Weeks 0 and 2

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.